233 related articles for article (PubMed ID: 35204374)
1. Bladder Microbiome in the Context of Urological Disorders-Is There a Biomarker Potential for Interstitial Cystitis?
Bschleipfer T; Karl I
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204374
[TBL] [Abstract][Full Text] [Related]
2. The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome.
Nickel JC; Ehrlich GD; Krol JE; Ahmed A; Sen B; Bhat A; Mell JC; Doiron RC; Kelly KL; Earl JP
BJU Int; 2022 Jan; 129(1):104-112. PubMed ID: 34143561
[TBL] [Abstract][Full Text] [Related]
3. Cultivable Bacteria in Urine of Women With Interstitial Cystitis: (Not) What We Expected.
Jacobs KM; Price TK; Thomas-White K; Halverson T; Davies A; Myers DL; Wolfe AJ
Female Pelvic Med Reconstr Surg; 2021 May; 27(5):322-327. PubMed ID: 32265402
[TBL] [Abstract][Full Text] [Related]
4. Female lower urinary tract microbiota do not associate with IC/PBS symptoms: a case-controlled study.
Bresler L; Price TK; Hilt EE; Joyce C; Fitzgerald CM; Wolfe AJ
Int Urogynecol J; 2019 Nov; 30(11):1835-1842. PubMed ID: 30993388
[TBL] [Abstract][Full Text] [Related]
5. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
6. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms.
Thomas-White K; Taege S; Limeira R; Brincat C; Joyce C; Hilt EE; Mac-Daniel L; Radek KA; Brubaker L; Mueller ER; Wolfe AJ
Am J Obstet Gynecol; 2020 Nov; 223(5):727.e1-727.e11. PubMed ID: 32791124
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
8. Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity?
Yıldırım S; Shoskes D; Kulkarni S; Laguna P
World J Urol; 2020 Nov; 38(11):2721-2731. PubMed ID: 32006175
[TBL] [Abstract][Full Text] [Related]
9. The Urinary Tract Microbiome in Health and Disease.
Aragón IM; Herrera-Imbroda B; Queipo-Ortuño MI; Castillo E; Del Moral JS; Gómez-Millán J; Yucel G; Lara MF
Eur Urol Focus; 2018 Jan; 4(1):128-138. PubMed ID: 28753805
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.
Akiyama Y
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943475
[TBL] [Abstract][Full Text] [Related]
11. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
Lin HY; Lu JH; Chuang SM; Chueh KS; Juan TJ; Liu YC; Juan YS
Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054241
[TBL] [Abstract][Full Text] [Related]
12. The Urinary Tract Microbiome: The Answer to All Our Open Questions?
Magistro G; Stief CG
Eur Urol Focus; 2019 Jan; 5(1):36-38. PubMed ID: 30042043
[TBL] [Abstract][Full Text] [Related]
13. Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Whitmore KE; Fall M; Sengiku A; Tomoe H; Logadottir Y; Kim YH
Int J Urol; 2019 Jun; 26 Suppl 1():26-34. PubMed ID: 31144757
[TBL] [Abstract][Full Text] [Related]
14. [The role of the microbiome in urological diseases].
Atzler M; Westhofen T; Tamalunas A; Schott M; Keller P; Ebner B; Stief C; Magistro G
Aktuelle Urol; 2021 Aug; 52(4):338-344. PubMed ID: 34102684
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis of the Urinary Bladder Microbiome in Cats with Chronic Kidney Disease.
Kim Y; Carrai M; Leung MHY; Chin J; Li J; Lee PKH; Beatty JA; Pfeiffer DU; Barrs VR
mSystems; 2021 Aug; 6(4):e0051021. PubMed ID: 34313465
[TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome.
Blalock EM; Korrect GS; Stromberg AJ; Erickson DR
J Urol; 2012 Feb; 187(2):725-32. PubMed ID: 22177197
[TBL] [Abstract][Full Text] [Related]
17. Clinical guidelines for interstitial cystitis/bladder pain syndrome.
Homma Y; Akiyama Y; Tomoe H; Furuta A; Ueda T; Maeda D; Lin AT; Kuo HC; Lee MH; Oh SJ; Kim JC; Lee KS
Int J Urol; 2020 Jul; 27(7):578-589. PubMed ID: 32291805
[TBL] [Abstract][Full Text] [Related]
18. Phenotyping of interstitial cystitis/bladder pain syndrome.
Akiyama Y; Hanno P
Int J Urol; 2019 Jun; 26 Suppl 1():17-19. PubMed ID: 31144756
[TBL] [Abstract][Full Text] [Related]
19. Urobiome: An outlook on the metagenome of urological diseases.
Shoemaker R; Kim J
Investig Clin Urol; 2021 Nov; 62(6):611-622. PubMed ID: 34729961
[TBL] [Abstract][Full Text] [Related]
20. β-Defensin 2, an Antimicrobial Peptide, as a Novel Biomarker for Ulcerative Interstitial Cystitis; Can β-Defensin 2 Suspect the Dysbiosis of Urine Microbiota?
Lee SW; Kim SH; Lee KW; Kim WB; Choi HW; Moon JE; Moon A; Kim YH
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
